Health Catalyst (HCAT) Q3 FY2026 earnings: revenue $56 million, down 26.3% on the year
Health Catalyst, Inc. (HCAT) reported revenue of $56 million for Q3 FY2026, the quarter ended 30 September 2026, down 26.3% on the same quarter a year earlier. Net income was $40 million, and diluted earnings per share $0.53. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.
Revenue
$56 million
-26.3% on the year · -20.2% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
89.1%
-22.9% a year earlier
Q4 FY2024Q3 FY2026
Net income
$40 million
Q4 FY2024Q3 FY2026
Diluted EPS
$0.53
Q4 FY2024Q3 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 2 kept.
Revenue above guided range, down year-on-year: Total revenue was $56.3 million against $76.3 million a year earlier, above the prior $55 million to $56 million quarterly range.
Net income driven by Vitalware gain: Net income was $40.5 million, against a $22.2 million loss a year earlier; the company attributed it largely to a $65.9 million gain on sale of the Vitalware business.
Adjusted EBITDA near breakeven: Adjusted EBITDA was $0.8 million against $12.0 million a year earlier, above the prior $0 to $0.5 million quarterly range. Adjusted gross margin was 44% against 53%.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
-1.9
0.3
-0.5
Capital expenditure
0.2
0.3
0.3
-54.8%
-38.8%
Free cash flow
-2.0
-0.1
-0.7
Free cash flow margin
-3.6%
-0.1%
-0.9%
Cash from investing
158
0.9
-9.4
+17,404.0%
Cash from financing
-163
-0.5
-0.5
Depreciation and amortisation
9.7
11.0
12.6
-11.4%
-22.9%
Share-based compensation
4.1
2.7
7.0
+50.5%
-42.1%
Buybacks
0.0
0.0
0.0
Diluted shares, weighted
76m
74m
70m
+2.7%
+7.9%
Shares outstanding at period end
76m
75m
71m
+2.1%
+7.8%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
146
101
332
+44.4%
-56.1%
Debt
0.0
153
153
Operating lease liabilities
12.1
12.8
15.1
-5.5%
-20.0%
Other liabilities
79.7
91.5
86.9
-12.9%
-8.3%
Total liabilities and equity
237
359
587
-33.8%
-59.6%
Fixed assets
34.5
33.5
32.6
+2.9%
+5.7%
Goodwill
11.1
11.1
286
+0.0%
-96.1%
Intangible assets
50.1
56.1
89.6
-10.8%
-44.1%
Investments
25.2
42.9
51.2
-41.1%
-50.7%
Cash and equivalents
53.7
60.6
40.3
-11.3%
+33.3%
Receivables
41.3
41.9
60.1
-1.4%
-31.2%
Other assets
21.5
113
27.7
-80.9%
-22.6%
Total assets
237
359
587
-33.8%
-59.6%
Questions
What was Health Catalyst's revenue in Q3 FY2026?
Health Catalyst (HCAT) reported revenue of $56 million for Q3 FY2026, the quarter ended 30 September 2026, down 26.3% on the same quarter a year earlier.
How much did Health Catalyst earn in Q3 FY2026?
Net income for Q3 FY2026 was $40 million, and diluted earnings per share $0.53.
When did Health Catalyst report Q3 FY2026 results?
Health Catalyst filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.